Why Private Prescription Makes Wegovy vs Mounjaro Choice Faster
Which Is Best Wegovy or Mounjaro: Private vs NHS Route Comparison
When determining which is best wegovy or mounjaro, the NHS route requires GP referral to specialist weight management services, often involving 6-month waiting lists and strict eligibility criteria. Private prescription eliminates these barriers entirely, offering direct access to both treatments through clinical assessment. EverydayMeds connects patients with UK prescribers who can evaluate your individual circumstances and recommend the most suitable option. Both medications require BMI ≥30 or BMI ≥27 with weight-related comorbidities, but private providers can often accommodate patients faster than overstretched NHS services.
The key difference lies in mechanism of action: Wegovy contains semaglutide, targeting GLP-1 receptors exclusively, whilst Mounjaro uses tirzepatide to activate both GIP and GLP-1 receptors simultaneously. This dual-action approach may offer different benefits for different patients, which your private prescriber can discuss during consultation. Rather than waiting months for specialist input, private prescription allows immediate access to expert medical guidance on which treatment aligns with your health profile and lifestyle requirements.
Wegovy vs Mounjaro Pricing: Complete Private Prescription Costs
Understanding which is best wegovy or mounjaro often comes down to cost considerations for private patients. Wegovy pricing starts from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99 and Ultimate Stability Trio (three 2.4mg pens) for £649.99. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 for additional savings.
Mounjaro pricing follows a different structure due to its distinct dosing schedule, but both treatments require similar long-term financial commitment. The prescription-only medicine status means both require ongoing clinical supervision, factored into EverydayMeds' comprehensive service pricing. Bundle packages offer convenience rather than pure savings—securing multiple months' supply through single orders reduces delivery frequency and ensures treatment continuity. Your prescriber can discuss cost-effectiveness based on your individual response and tolerance profile for each medication.
Clinical Evidence: Wegovy vs Mounjaro Trial Data
When evaluating which is best wegovy or mounjaro, clinical evidence shows both medications demonstrated significant efficacy in their respective trials. In the STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme also showed sustained benefits at 2 years, with STEP 5 demonstrating 15.2% maintained weight reduction.
Mounjaro's SURMOUNT trials showed promising results with tirzepatide's dual-receptor approach, though direct head-to-head comparisons remain limited due to different trial designs and populations. Both medications require administration alongside a reduced-calorie diet and increased physical activity to achieve optimal outcomes. Individual responses may vary significantly, making personalised medical guidance essential when choosing between treatments.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding which is best wegovy or mounjaro requires knowing how Wegovy functions within the body. Semaglutide acts as a GLP-1 receptor agonist, mimicking natural incretin hormones that regulate appetite and blood glucose levels. The medication binds to GLP-1 receptors in the brain's appetite centres, promoting feelings of fullness after smaller meals and reducing food cravings between eating occasions. This mechanism may help patients achieve sustainable portion control without the constant hunger often associated with traditional calorie-restricted diets. Weekly subcutaneous injection via the FlexTouch pen delivers consistent medication levels, supporting steady appetite regulation throughout the treatment period.
Private Prescription Ordering Process: Assessment to Delivery
Accessing either treatment when considering which is best wegovy or mounjaro begins with EverydayMeds' streamlined 3-minute clinical assessment covering medical history, current medications, and weight management goals. UK-qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring clinical suitability before approving treatment. Once approved, next-day delivery utilises temperature-controlled cold-chain logistics to maintain medication integrity from our GPhC-registered pharmacy #9012878. The entire process eliminates traditional barriers like GP appointments, specialist referrals, and lengthy waiting lists that often delay NHS provision. Ongoing clinical support remains available throughout treatment via secure patient portals and direct prescriber communication channels.
Storage and Practical Considerations: Wegovy vs Mounjaro
Practical factors may influence which is best wegovy or mounjaro for your lifestyle circumstances. Wegovy offers superior storage flexibility, remaining stable for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This advantage benefits frequent travellers or those with limited refrigeration access, providing greater treatment flexibility without compromising medication efficacy. Both medications use pre-filled injection pens requiring refrigerated storage at 2-8°C before first use, with dose escalation protocols that cannot be skipped or accelerated. Wegovy's proven FlexTouch delivery system offers reliable dosing accuracy across the 20-week escalation period from 0.25mg starter dose to 2.4mg maintenance level.
Which Is Best Wegovy or Mounjaro: Personalised Treatment Selection
Determining which is best wegovy or mounjaro ultimately depends on individual patient factors including previous treatment responses, comorbidities, and lifestyle preferences. Wegovy's established clinical profile and longer market presence provide extensive real-world safety data, whilst Mounjaro's dual-receptor mechanism may offer advantages for specific patient populations. Private prescription allows detailed consultation about family history, previous weight loss attempts, and concurrent medications that might influence treatment choice.
Some patients respond better to single-receptor targeting (Wegovy), whilst others may benefit from dual-pathway activation (Mounjaro). Your prescriber can evaluate factors like diabetes risk, cardiovascular health, and gastrointestinal tolerance to recommend the most appropriate option. Both treatments remain available from EverydayMeds, ensuring flexibility to switch medications if initial choice proves unsuitable or side effects develop during treatment.
Start Your Private Prescription Journey Today
Rather than prolonging the decision about which is best wegovy or mounjaro through extended NHS waiting periods, private prescription offers immediate access to expert medical guidance and treatment initiation. EverydayMeds' comprehensive service includes ongoing clinical monitoring, dose adjustment support, and direct prescriber access throughout your weight management journey. New customers can begin with our 3-minute assessment and apply discount code FIRST40 at checkout, with returning patients using DOSE25 for additional savings. Visit https://everydaymeds.co.uk/collections/wegovy to start your assessment today, connecting with UK prescribers who can help determine which treatment aligns with your individual health goals and circumstances. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
